Ancillary Study: Contribution of Specified Opioid Receptor Gene Variants to Outcome of Extended Release Naltrexone vs. Buprenorphine/Naloxone Treatment for Opioid Dependence Investigators:  John Rotrosen, M.D. (NYU Langone Medical Center); Ancillary Study: Mary Jeanne Kreek, M.D. (Rockefeller University) Status:  Available at dbGaP dbGaP Accession ID:  phs002876.v1.p1 dbGaP Release Date: 05/25/2022 Abstract:  For opioid-dependent patients in the … Continue reading Study 31 – Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT); CTN-0051